BRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025

Reuters12-17

BRIEF-<a href="https://laohu8.com/S/ALVO">Alvotech</a> SA Reaffirmed Full Year Outlook For 2025

Dec 17 (Reuters) - Alvotech SA ALVO.O:

ALVOTECH SA - REAFFIRMED FULL YEAR OUTLOOK FOR 2025
ALVOTECH SA - ANTICIPATES 2026 TOTAL REVENUES IN THE RANGE OF $650-$700 MILLION
ALVOTECH SA - 2026 GUIDANCE TAKES INTO ACCOUNT IMPACT OF ANY FURTHER DELAYS IN OBTAINING CERTAIN MARKETING APPROVAL FROM U.S. FDA

Source text: [ID:n0001171843-25-007974]

Further company coverage: ALVO.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2592916624?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-17 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2592916624","market":"us","top_or_hot":-1,"title":"BRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> SA Reaffirmed Full Year Outlook For 2025</title></head><body><p><span>Dec 17 (Reuters)</span><span> - </span>Alvotech SA <span>ALVO.O</span>:</p><ul><li><p>ALVOTECH SA -  REAFFIRMED FULL YEAR OUTLOOK FOR 2025</p></li><li><p>ALVOTECH SA -  ANTICIPATES 2026 TOTAL REVENUES IN THE RANGE OF $650-$700 MILLION</p></li><li><p>ALVOTECH SA -  2026 GUIDANCE TAKES INTO ACCOUNT IMPACT OF ANY FURTHER DELAYS IN OBTAINING CERTAIN MARKETING APPROVAL FROM U.S. FDA</p></li></ul><p>Source text: [ID:n0001171843-25-007974]</p><p>Further company coverage: <span>ALVO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-12-17 22:44</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/ALVO\">Alvotech</a> SA Reaffirmed Full Year Outlook For 2025</title></head><body><p><span>Dec 17 (Reuters)</span><span> - </span>Alvotech SA <span>ALVO.O</span>:</p><ul><li><p>ALVOTECH SA -  REAFFIRMED FULL YEAR OUTLOOK FOR 2025</p></li><li><p>ALVOTECH SA -  ANTICIPATES 2026 TOTAL REVENUES IN THE RANGE OF $650-$700 MILLION</p></li><li><p>ALVOTECH SA -  2026 GUIDANCE TAKES INTO ACCOUNT IMPACT OF ANY FURTHER DELAYS IN OBTAINING CERTAIN MARKETING APPROVAL FROM U.S. FDA</p></li></ul><p>Source text: [ID:n0001171843-25-007974]</p><p>Further company coverage: <span>ALVO.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XN0AN:1","article_id":"2592916624","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2592916624","pubTimestamp":1765982652,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025Dec 17  - Alvotech SA ALVO.O:ALVOTECH SA -  REAFFIRMED FULL YEAR OUTLOOK FOR 2025ALVOTECH SA -  ANTICIPATES 2026 TOTAL REVENUES IN THE RANGE OF $650-$700 MILLIONALVOTECH SA -  2026 GUIDANCE TAKES INTO ACCOUNT IMPACT OF ANY FURTHER DELAYS IN OBTAINING CERTAIN MARKETING APPROVAL FROM U.S. FDASource text: [ID:n0001171843-25-007974]Further company coverage: ALVO.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","ALVO":"Alvotech"},"translate_title":"简介-Alvotech SA重申2025年全年展望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALVO":0.9},"content_text":"BRIEF-Alvotech SA Reaffirmed Full Year Outlook For 2025Dec 17 (Reuters) - Alvotech SA ALVO.O:ALVOTECH SA -  REAFFIRMED FULL YEAR OUTLOOK FOR 2025ALVOTECH SA -  ANTICIPATES 2026 TOTAL REVENUES IN THE RANGE OF $650-$700 MILLIONALVOTECH SA -  2026 GUIDANCE TAKES INTO ACCOUNT IMPACT OF ANY FURTHER DELAYS IN OBTAINING CERTAIN MARKETING APPROVAL FROM U.S. FDASource text: [ID:n0001171843-25-007974]Further company coverage: ALVO.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2592916624","isCrawlerRequest":true}